Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | HTR5A | P47898 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CASP6 | P55212 | 1/20 | 0.40 |
| ▸ | DYRK2 | Q92630 | 2/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23057357 | 0.88 | ADRA1A (0.47) | HTR2CHTR2BHTR5AADRA1AADRA1B | |
| SCHEMBL23057359 | 0.78 | BRD4 (0.50) | ADRA1AADRA1BMEN1KMT2AALDH1A1 | |
| SCHEMBL5432407 | 0.70 | ALDH1A1 (0.64) | MEN1KMT2AALDH1A1HPGDKDM4E | |
| Lycogarubin B SCHEMBL31061720 | 0.68 | HTT (0.50) | HTR2CHTR2BHTR5AADRA1AADRA1B | |
| SCHEMBL3333256 | 0.68 | MEN1 (0.50) | MEN1KMT2AALDH1A1HPGDKDM4E | |
| Lycogalic Acid A SCHEMBL12955978 | 0.67 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1HPGDKDM4E | |
| Lycogalic Acid A SCHEMBL29465596 | 0.67 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1HPGDKDM4E | |
| SCHEMBL5426730 | 0.66 | PTPN1 (0.54) | HTR2CHTR2BHTR5AKMT2AALDH1A1 | |
| SCHEMBL5435851 | 0.66 | HTR2C (0.56) | HTR2CHTR2BHTR5AMEN1KMT2A | |
| SCHEMBL5960522 | 0.65 | PTPN1 (0.51) | ALDH1A1HPGDKDM4EDYRK2CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | claimed |
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | OCTARINE BIO APS (DK) | 2026-04-02 | — | — | US | disclosed |
| WO-2026042066-A1 | COMPOUNDS, COMPOSITIONS, AND USE THEREOF FOR TREATING INFLAMMATORY AND/OR AUTOIMMUNE DISEASES | I DERM PHARMA LTD. (IL) | 2026-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092179-A1 | GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF | TDO2, BLVRB, INMT | HTR2C 533/4885HTR2B 996/4885HTR5A 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.